Distribution of men and women in the BNA sample according to age.

<p>Distribution of men and women in the BNA sample according to age.</p

Patients with Alzheimer's disease and related disorders: the MMSE score at the time of first diagnosis according to age.

<p>Patients with Alzheimer's disease and related disorders: the MMSE score at the time of first diagnosis according to age.</p

Additional file 1: of Antipsychotic prescribing for Alzheimer’s disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study

Prevalence of antipsychotic prescribing in the community and in long-term care facilities. (DOCX 49 kb

Patient with Alzheimer's disease and related disorders: MMSE score at the time of first diagnosis according to age and educational level.

<p>Patient with Alzheimer's disease and related disorders: MMSE score at the time of first diagnosis according to age and educational level.</p

Patients with Alzheimer's disease and related disorders: MMSE score at the time of first diagnosis according to age, educational level and gender.

<p>Patients with Alzheimer's disease and related disorders: MMSE score at the time of first diagnosis according to age, educational level and gender.</p

Selection of the patients included in the study.

<p>Selection of the patients included in the study.</p

Receiver operating characteristic curve for the ability of plasma hyaluronic acid to predict liver-related events.

<p>Receiver operating characteristic curve for the ability of plasma hyaluronic acid to predict liver-related events.</p

Adjusted incidence rate ratios of any liver-related events.

<p>Note: The horizontal lines indicate 95% confidence intervals; HA: hyaluronic acid; HBsAg: hepatitis B surface antigen; HCVab: anti-HCV antibody; Group 1: HBsAg positive and/or anti-HCV/HCV-RNA positive; Group 2: anti-HCV positive/HCV-RNA negative.</p

Distribution of plasma hyaluronic acid levels and any-liver related events during follow-up.

<p>Distribution of plasma hyaluronic acid levels and any-liver related events during follow-up.</p

Adjusted incidence rate ratios of any non-liver-related events.

<p>Note: The horizontal lines indicate 95% confidence intervals; HA: hyaluronic acid; HBsAg: hepatitis B surface antigen; HCVab: anti-HCV antibody; Group 1: HBsAg positive and/or anti-HCV/HCV-RNA positive; Group 2: anti-HCV positive/HCV-RNA negative.</p